Shopping Cart
Remove All
Your shopping cart is currently empty
6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. 6β-PGI1 has a much longer half-life than PGI2, but a greatly reduced molar potency for receptor mediated function. 6β-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 μM compared with 18 nM for PGI2. The potency for vasodilation and inhibition of platelet aggregation is about 1% of PGI2.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $232 | 35 days | 35 days | |
| 5 mg | $993 | 35 days | 35 days | |
| 10 mg | $1,790 | 35 days | 35 days |
| Description | 6β-PGI1 is a stable PGI2 analog resistant to hydrolysis in aqueous solutions. 6β-PGI1 has a much longer half-life than PGI2, but a greatly reduced molar potency for receptor mediated function. 6β-PGI1 has a Kact for adenylate cyclase in NCB-20 cells of 4.2 μM compared with 18 nM for PGI2. The potency for vasodilation and inhibition of platelet aggregation is about 1% of PGI2. |
| Synonyms | 6β-Prostaglandin I1 |
| Molecular Weight | 354.487 |
| Formula | C20H34O5 |
| Cas No. | 62770-50-7 |
| Smiles | [H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C[C@H](CCCCC(O)=O)O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: >10 (from 6b-PGI1), Sonication is recommended. DMSO: >5 (from 6b-PGI1), Sonication is recommended. PBS (pH 7.2): >80 μg (from 6b-PGI1), Sonication is recommended. Ethanol: >20 mg/mL (from 6b-PGI1), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.